HomeAI · summaries
Storia in 3 fonti
NEJM Retracts Pivotal Trial of FDA-Approved Drug
Move follows actions 'inconsistent with proper research conduct,' journal says
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
NEJM retracts pivotal data for Amgen's Tavneos
NEJM retracts pivotal data behind Amgen's Tavneos after FDA probe finds results for 9 patients re-evaluated post-unblinding; EU also moves to revoke.
- ·
jpost.com
FDA findings lead to medical journal paper retraction | The Jerusalem Post
An Amgen spokesperson said it "takes scientific integrity seriously and respects the role of journals in upholding the peer review process."
